Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-09-07
DOI
10.1080/14656566.2020.1811850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies
- (2019) Giuseppe Vita et al. NEUROLOGICAL SCIENCES
- Burden of Hereditary Transthyretin Amyloidosis on Quality of Life
- (2019) Aaron Yarlas et al. MUSCLE & NERVE
- Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)
- (2018) Alejandra Gonzalez-Duarte CLINICAL AUTONOMIC RESEARCH
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
- (2018) Violaine Planté-Bordeneuve et al. EXPERT OPINION ON PHARMACOTHERAPY
- Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
- (2017) David M. Phillippo et al. MEDICAL DECISION MAKING
- Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial
- (2017) Peter J. Dyck et al. MUSCLE & NERVE
- Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe
- (2016) Yesim Parman et al. CURRENT OPINION IN NEUROLOGY
- Evolving landscape in the management of transthyretin amyloidosis
- (2015) Philip N. Hawkins et al. ANNALS OF MEDICINE
- Liver transplantation in transthyretin amyloidosis: Issues and challenges
- (2015) Andreia Carvalho et al. LIVER TRANSPLANTATION
- Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials
- (2014) N. Suanprasert et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy
- (2014) Etta J. Vinik et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
- (2014) Jeroen P. Jansen et al. VALUE IN HEALTH
- Guideline of transthyretin-related hereditary amyloidosis for clinicians
- (2013) Yukio Ando et al. Orphanet Journal of Rare Diseases
- Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
- (2012) James E. Signorovitch et al. VALUE IN HEALTH
- Familial amyloid polyneuropathy
- (2011) Violaine Planté-Bordeneuve et al. LANCET NEUROLOGY
- Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
- (2011) Jeroen P. Jansen et al. VALUE IN HEALTH
- Comparative Effectiveness Without Head-to-Head Trials
- (2010) James E. Signorovitch et al. PHARMACOECONOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started